Eli Lilly & Company

Type: Company
Name: Eli Lilly & Company (Eli Lilly and Company)
First reported 6 hours ago - Updated 6 hours ago - 1 reports

DoverPac®

Source: ILC DoverThe system was designed in collaboration with Eli Lilly to provide high levels of reliable containment during both charging and offloading operations. The system consists of a tough fabric outer restraint and a durable film liner.Request ... [Published Surface Finishing .com - 6 hours ago]
First reported 10 hours ago - Updated 10 hours ago - 1 reports

Lilly and T1D Exchange Announce Research Collaboration to Inform Development of New Initiatives to Advance Diabetes Care

(NewsRx) -- By a News Reporter-Staff News Editor at Diabetes Week -- T1D Exchange and Eli Lilly and Company (NYSE: LLY) announced they have entered into a research collaboration that will enable both organizations to gain deeper, real-world insight about ... [Published NewsRX - 10 hours ago]
First reported 18 hours ago - Updated 18 hours ago - 1 reports

ELI LILLY : Lilly shares hit all-time high for the John Lechleiter era

Investors got excited after a federal judge in Indianapolis late last month decided in favor of Eli Lilly and Co. in its latest patent case.The decision, unless reversed on appeal, ensures nearly six more years of exclusive sales of Lilly's lung cancer ... [Published 4 Traders - 18 hours ago]
First reported Apr 18 2014 - Updated Apr 18 2014 - 1 reports

Dollars for Doctors

WESLACO - Some Rio Grande Valley doctors get thousands of dollars in cash, and other forms of payment, from pharmaceutical companies.The totals climb into six figures for some. The payments are not illegal, but medical ethicists, and even the federal ... [Published KRGV - Apr 18 2014]
First reported Apr 18 2014 - Updated Apr 18 2014 - 1 reports

Big pharma struggles to balance transparency and profits

Mark Lanier is no ordinary trial lawyer. His success has been such that he lives on a 25-acre estate near Houston and hosts lavish parties for hundreds of people each Christmas with entertainment provided in recent years by Miley Cyrus, Bon Jovi and ... [Published Irish Times - Apr 18 2014]
First reported Apr 18 2014 - Updated Apr 18 2014 - 1 reports

Lilly To Release Early-Stage Pipeline Data Targeting Key Cancer Pathways At AACR 2014

(NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Eli Lilly and Company (NYSE: LLY) will present early-stage data from several targeted cancer therapies - including bemaciclib "beh meh sye' klib" (LY2835219), its oral, cell-cycle ... [Published NewsRX - Apr 18 2014]
First reported Apr 17 2014 - Updated Apr 17 2014 - 2 reports

Eli Lilly Enlists Congress In Fight Against Canada For Refusing Patent On Useless Drug

from the war-on-all-fronts dept Eli Lilly bet its entire business model on patents years back, rather than on creating useful products that people want to buy. Lately it's been having trouble getting new patents, and is reacting extremely poorly to the ... [Published Techdirt - Apr 17 2014]
First reported Apr 17 2014 - Updated Apr 17 2014 - 1 reports

Anti social? Big Pharma balks at US FDA social media guidance

Comments from Novartis, Eli Lilly and Pfizer revealed that industry is taking serious issue with some aspects of the draft guidance from the US FDA on social media and promotional materials online.All three drugmakers focused their critiques on the Food ... [Published In-Pharmatechnologist - Apr 17 2014]
First reported Apr 17 2014 - Updated Apr 17 2014 - 1 reports

Which therapies top Thomson Reuters list of new drugs to watch this year?

The industry analysts at Thomson Reuters put their heads together to tap the biggest new blockbusters in the making this year and surprised no one by capping the list with Gilead's ($GILD) Sovaldi.The new hep C treatment has been sparking a nationwide ... [Published FierceBiotech - Apr 17 2014]
First reported Apr 17 2014 - Updated Apr 17 2014 - 1 reports

Lilly, T1D Exchange ink diabetes research collaboration

Eli Lilly has entered into a multi-year research collaboration with T1D Exchange, the first programme launched by US-based non-profit Unitio, to gather real-world insights into the experiences of people with . The collaboration will involve multiple projects ... [Published Pharma Times - Apr 17 2014]
First reported Apr 17 2014 - Updated Apr 17 2014 - 1 reports

Potential Eli Lilly (LLY) Trade Targets 3.11% Return

Wednesday’s trading in Eli Lilly and Co (LLY) gives options traders an opportunity for a 16.55% return. By selling the Jun. '14 $60.00 call and buying the Jan. '15 call at the $50.00 level for a net debit of $8.58, traders will book a profit as long as ... [Published MarketIntelligenceCenter.com - Apr 17 2014]
First reported Apr 17 2014 - Updated Apr 17 2014 - 1 reports

More than 700 jobs up for grabs at biopharma fair

Ireland is home to 13 of the world's top 15 pharmaceutical companies – but executives say they are struggling to fill some roles and warned of serious shortages of qualified candidates in some areas.Real-world training and upskilling is needed because ... [Published Irish Independent - Apr 17 2014]

Quotes

...SCT is featured in 136 pages of its January issue. Included are claims that the question of its existence "seems to be laid to rest as of this issue" and that SCT is gaining momentum toward recognition as a legitimate disorder
...The trade group thinks the draft makes this assumption, but warns that to do so "could chill truthful and non-misleading communication protected by the First Amendment." BIO and Pfizer also picked holes in this aspect of the draft, with the New York-based drugmaker warning it represents "jurisdictional creep" by the...
"Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics" Now Available at Fast Market Research
"However, pipeline excitement put the stock back on track again starting in late 2011," Anderson added, "and looking forward into 2014 there are likely to be several reasonably important data sets that get released."

More Content

All (1758) | News (1519) | Reports (0) | Blogs (190) | Audio/Video (1) | Fact Sheets (18) | Press Releases (25)
sort by: Date | Relevance
DoverPac® [Published Surface Finishing .com - 6 hours ago]
Lilly and T1D Exchange Announce Research Collab... [Published NewsRX - 10 hours ago]
No Child Left Undiagnosed [Published Psychiatric Times - 11 hours ago]
Royalty Financing Partnering Terms and Agreemen... [Published SBWire - 13 hours ago]
Pfizer, PhRMA and others pick holes in FDA soci... [Published Fierce Biotech IT - 13 hours ago]
"Option and Evaluation Partnering Terms and Agr... [Published SBWire - 14 hours ago]
Limelight v. Akamai Briefs Hit Joint Patent Inf... [Published Bureau of National Affairs - 14 hours ago]
Reduce Dispensing Errors Using a Controlled Pac... [Published PPP Mag.com - 14 hours ago]
Thomson Reuters Names Drugs to Watch in 2014 [Published PharmTech.com - 15 hours ago]
EMA update on stolen vials of Herceptin [Published Pharma Letter - 16 hours ago]
Sreedhar Nair, MD [Published Wilton Bulletin - 17 hours ago]
Asset Purchase Terms and Agreements in Pharma, ... [Published SBWire - 17 hours ago]
Recent Study: Personalized Medicine Partnering ... [Published Digital Journal - 18 hours ago]
ELI LILLY : Lilly shares hit all-time high for ... [Published 4 Traders - 18 hours ago]
New Market Study Published: Dyslipidemia - Pipe... [Published Digital Journal - 18 hours ago]
Cohen’s Point72 Asset Management buys a stake i... [Published Yahoo! Finance - 20 hours ago]
Clinical Trial Experts to Discuss Relationship ... [Published PRWeb - 20 hours ago]
Alkermes CEO Richard Pops on Building Big and P... [Published Xconomy - 21 hours ago]
India’s Patent Laws Comes Under Western Scrutiny [Published Spy Ghana - 22 hours ago]
Mark Lanier to Share Legal Perspectives at 2 Up... [Published PRWeb - Apr 18 2014]
Dollars for Doctors [Published KRGV - Apr 18 2014]
Big pharma struggles to balance transparency an... [Published Irish Times - Apr 18 2014]
Lilly To Release Early-Stage Pipeline Data Targ... [Published NewsRX - Apr 18 2014]
EMA Has Update on Herceptin Theft, Adds 2 New D... [Published Diabetes Care - Apr 17 2014]
Here's what will drive stocks next week [Published CNBC - Apr 17 2014]
Eli Lilly Enlists Congress In Fight Against Can... [Published Techdirt - Apr 17 2014]
Eli Lilly Enlists Congress In Fight Against Can... [Published Techdirt - Apr 17 2014]
Why daydreaming may be the next childhood psych... [Published Deseret Morning News - Apr 17 2014]
Thomas Reuters Projects Next Blockbusters [Published The Big Red Biotech Blog - Apr 17 2014]
Anti social? Big Pharma balks at US FDA social ... [Published In-Pharmatechnologist - Apr 17 2014]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Eli Lilly Enlists Congress In Fight Against Can... [Published Techdirt - Apr 17 2014]
Eli Lilly bet its entire business model on patents years back, rather than on creating useful products that people want to buy. Lately it's been having trouble getting new patents, and is reacting extremely poorly to the fact that its last-gasp efforts ...
Thomas Reuters Projects Next Blockbusters [Published The Big Red Biotech Blog - Apr 17 2014]
Thomas Reuters analysts just projected the next round of drugs that they feel should be watched a the new blockbusters on the block in the coming year. The list has some sure things and perhaps some surprises. In order of liklihood and sales: Gilead's ...
Potential Eli Lilly (LLY) Trade Targets 3.11% R... [Published MarketIntelligenceCenter.com - Apr 17 2014]
Wednesday’s trading in Eli Lilly and Co (LLY) gives options traders an opportunity for a 16.55% return. By selling the Jun. '14 $60.00 call and buying the Jan. '15 call at the $50.00 level for a net debit of $8.58, traders will book a profit as long as ...
These Numbers Show That Box CEO Aaron Levie Is ... [Published Clusterstock - Apr 17 2014]
When Box filed "> its long-awaited paperwork to become a public company, it caused a lot of talk about the financial health of the company, and the long-term viability of its business model. At issue was how much money Box is spending compared ...
Potential Eli Lilly (LLY) Trade Has 2.63% Downs... [Published MarketIntelligenceCenter.com - Apr 16 2014]
After closing Tuesday at $59.42, Eli Lilly and Co (LLY) presents an attractive opportunity to get a 3.70% return in just 66 days, which is an annualized return of 20.45% (for comparison purposes only). To enter this trade, sell one Jun. '14 $60.00 call ...
1 2 3 4 5 6 7 8 9 10 ...

Audio/Video

sort by: Date | Relevance
Economy Grows At A Healthy Clip [Published Wall Street Journal What's News - Jan 30 2014]
1

Press Releases

sort by: Date | Relevance
Zacks Industry Outlook Highlights: Eli Lilly, A... [Published Financial Services - Mar 27 2014]
The Zacks Analyst Blog Highlights:Royal Dutch S... [Published Financial Services - Mar 18 2014]
Elanco Announces Agreement to Acquire Lohmann A... [Published Financial Services - Feb 24 2014]
Fitch Rates Eli Lilly's $1B Notes Issuance 'A' [Published Fitch Ratings Headlines Corporate - Feb 21 2014]
Sanofi Files Suit in The U.S. To Defend Its Pat... [Published GlobeNewswire: Acquisitions News - Jan 30 2014]
1 2 3 4 5
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.